← All indications
Borderline Personality Disorder
A personality disorder marked by a pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity beginning by early adulthood and present in a variety of contexts. (DSM-IV)
Drugs by status
Approved for this indication (1)
Phase 4 trials (6)
Phase 3 trials (6)
Phase 2 trials (15)
Phase 1 trials (3)
Other trials (5)
Organizations
Organization Involved with Phase 4 Indications (7)
Organization Involved with Phase 3 Indications (9)
Organization Involved with Phase 2 Indications (21)
- Pfizer
- Hannover Clinical Trial Center GmbH
- Boehringer Ingelheim
- Columbia Northwest Pharmaceuticals
- Temple University
- Gottfried Wilhelm Leibniz Universität Hannover
- Indiana University
- Monash University
- New York University
- Northwestern University
- Ohio State University
- University of Chicago
- The Alfred Hospital
- University of Freiburg
- University of Barcelona
- Northwest Clinical Research Center
- Artemis Institute for Clinical Research
- National Center for Advancing Translational Science (NCATS)
- American Foundation for Suicide Prevention
- University of Southern Mississippi
- Government of Spain
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (4)